Work

MCF7/LCC2: a 4-hydroxytamoxifen resistant human breast cancer variant that retains sensitivity to the steroidal antiestrogen ICI 182,780.

Year: 1993

Type: article

Source: PubMed

Authors: N Brünner, T L Frandsen, C Holst-Hansen, M Bei, E W Thompson, A E Wakeling, M E Lippman, R Clarke

Institutions: Georgetown University, Georgetown University Medical Center, Georgetown Lombardi Comprehensive Cancer Center, University of Copenhagen, AstraZeneca (United Kingdom)

Language: English

Topic: Estrogen and related hormone effects

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Cancer Institute

Awards: GROWTH REGULATION AS TARGETS IN BREAST CANCER TREATMENT, ESTROGEN INDUCED PROGRESSION IN BREAST CANCER, HORMONAL AUTONOMY IN HORMONE DEPENDENT TUMORS

OpenAlex ID: W1509083932

FWCI: 2.599

Cites:

Cited by: 103

Related to: 10